Dis-Chem Pharmacies Limited

Informe acción JSE:DCP

Capitalización de mercado: R28.3b

Dis-Chem Pharmacies Dirección

Dirección controles de criterios 2/4

El CEO de Dis-Chem Pharmacies' es Rui Morais , nombrado en Jul 2023, tiene una permanencia de menos de un año. compensación anual total es ZAR18.12M, compuesta por 64.2% salario y 35.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.99% de las acciones de la empresa, por valor de ZAR259.97M. La antigüedad media del equipo directivo y de la junta directiva es de 1.8 años y 3.3 años, respectivamente.

Información clave

Rui Morais

Chief Executive Officer (CEO)

R18.1m

Compensación total

Porcentaje del salario del CEO64.2%
Permanencia del CEOless than a year
Participación del CEO1.0%
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva3.3yrs

Actualizaciones recientes de la dirección

Recent updates

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Rui Morais en comparación con los beneficios de Dis-Chem Pharmacies?
FechaCompensación totalSalarioIngresos de la empresa
Aug 31 2023n/an/a

R899m

May 31 2023n/an/a

R949m

Feb 28 2023R18mR12m

R1b

Nov 30 2022n/an/a

R1b

Aug 31 2022n/an/a

R1b

May 31 2022n/an/a

R946m

Feb 28 2022R14mR11m

R853m

Nov 30 2021n/an/a

R815m

Aug 31 2021n/an/a

R776m

May 31 2021n/an/a

R722m

Feb 28 2021R6mR6m

R669m

Nov 30 2020n/an/a

R655m

Aug 31 2020n/an/a

R641m

May 31 2020n/an/a

R620m

Feb 29 2020R6mR6m

R598m

Nov 30 2019n/an/a

R573m

Aug 31 2019n/an/a

R549m

May 31 2019n/an/a

R634m

Feb 28 2019R5mR5m

R719m

Nov 30 2018n/an/a

R718m

Aug 31 2018n/an/a

R718m

May 31 2018n/an/a

R701m

Feb 28 2018R7mR5m

R684m

Compensación vs. Mercado: La compensación total ($USD953.09K) de Rui está en línea con el promedio de empresas de tamaño similar en el mercado ZA ($USD961.57K).

Compensación vs. Ingresos: La compensación de Rui ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.


CEO

Rui Morais (39 yo)

less than a year

Permanencia

R18,122,000

Compensación

Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Rui Morais
CEO & Executive Directorless than a yearR18.12m0.99%
ZAR 279.4m
J. Pope
CFO & Executive Directorless than a yearR3.43msin datos
Ivan Saltzman
Executive Directorless than a yearR19.17msin datos
Lynette Saltzman
Managing Director19yrsR15.58msin datos
Saul Saltzman
Executive Director1.8yrsR7.66m0.43%
ZAR 122.9m
Stanley Richard Goetsch
Executive Director1.8yrsR7.63m4.64%
ZAR 1.3b
Christopher Williams
Prescribed Officerno dataR8.10msin datos
Craig Fairweather
Commercial Directorno dataR23.83m0.0045%
ZAR 1.3m
C. Swanepoel
Prescribed Officerno dataR4.48m0.0012%
ZAR 328.0k
T. Ponter
Prescribed Officerno dataR4.71msin datos
Caryn Barker
Human Resources Directorno datasin datossin datos
Nikki Lumley
Company Secretary3.2yrssin datossin datos

1.8yrs

Permanencia media

66yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DCP no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Rui Morais
CEO & Executive Director11.8yrsR18.12m0.99%
ZAR 279.4m
J. Pope
CFO & Executive Directorless than a yearR3.43msin datos
Ivan Saltzman
Executive Director19yrsR19.17msin datos
Saul Saltzman
Executive Director1.8yrsR7.66m0.43%
ZAR 122.9m
Stanley Richard Goetsch
Executive Director1.8yrsR7.63m4.64%
ZAR 1.3b
Laurence Nestadt
Independent Non-Executive Chairman7.6yrsR3.17m0.058%
ZAR 16.5m
Johannes Mthimunye
Independent Non-Executive Director7.6yrsR802.00k0.0095%
ZAR 2.7m
Anuschka Coovadia
Independent Non-Executive Director7.6yrsR598.00k0.019%
ZAR 5.3m
Alupheli Sithebe
Independent Non-Executive Director3.3yrsR598.00ksin datos
Katlego K. Kobue
Non-Independent Non Executive Director2.5yrsR484.00ksin datos
Happy Masondo
Independent Non-Executive Director1.8yrsR423.00k0%
ZAR 0

3.3yrs

Permanencia media

52.5yo

Promedio de edad

Junta con experiencia: La junta directiva de DCP se considera experimentada (3.3 años de antigüedad promedio).